Grant E. Nybakken, Ph.D. - Publications

Affiliations: 
2008 Washington University, Saint Louis, St. Louis, MO 
Area:
Molecular Biology, Medical Biophysics, Virology Biology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Cherrier MV, Kaufmann B, Nybakken GE, Lok SM, Warren JT, Chen BR, Nelson CA, Kostyuchenko VA, Holdaway HA, Chipman PR, Kuhn RJ, Diamond MS, Rossmann MG, Fremont DH. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. The Embo Journal. 28: 3269-76. PMID 19713934 DOI: 10.1038/Emboj.2009.245  0.773
2008 Lok SM, Kostyuchenko V, Nybakken GE, Holdaway HA, Battisti AJ, Sukupolvi-Petty S, Sedlak D, Fremont DH, Chipman PR, Roehrig JT, Diamond MS, Kuhn RJ, Rossmann MG. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nature Structural & Molecular Biology. 15: 312-7. PMID 18264114 DOI: 10.1038/Nsmb.1382  0.751
2008 Kuhn RJ, Kaufmann B, Lok SM, Cherrier M, Perera R, Sedlak D, Nybakken GE, Chipman PR, Zhang W, Diamond MS, Fremont DH, Rossmann MG. Structural studies of West Nile virus in complex with neutralizing antibodies Bmc Proceedings. 2. DOI: 10.1186/1753-6561-2-s1-s25  0.695
2007 Pierson TC, Xu Q, Nelson S, Oliphant T, Nybakken GE, Fremont DH, Diamond MS. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host & Microbe. 1: 135-45. PMID 18005691 DOI: 10.1016/J.Chom.2007.03.002  0.76
2007 Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. Journal of Virology. 81: 12816-26. PMID 17881453 DOI: 10.1128/Jvi.00432-07  0.748
2007 Oliphant T, Nybakken GE, Austin SK, Xu Q, Bramson J, Loeb M, Throsby M, Fremont DH, Pierson TC, Diamond MS. Induction of epitope-specific neutralizing antibodies against West Nile virus. Journal of Virology. 81: 11828-39. PMID 17715236 DOI: 10.1128/Jvi.00643-07  0.744
2006 Chung KM, Liszewski MK, Nybakken G, Davis AE, Townsend RR, Fremont DH, Atkinson JP, Diamond MS. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proceedings of the National Academy of Sciences of the United States of America. 103: 19111-6. PMID 17132743 DOI: 10.1073/Pnas.0605668103  0.632
2006 Oliphant T, Nybakken GE, Engle M, Xu Q, Nelson CA, Sukupolvi-Petty S, Marri A, Lachmi BE, Olshevsky U, Fremont DH, Pierson TC, Diamond MS. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. Journal of Virology. 80: 12149-59. PMID 17035317 DOI: 10.1128/Jvi.01732-06  0.777
2006 Nybakken GE, Nelson CA, Chen BR, Diamond MS, Fremont DH. Crystal structure of the West Nile virus envelope glycoprotein. Journal of Virology. 80: 11467-74. PMID 16987985 DOI: 10.1128/Jvi.01125-06  0.625
2006 Kaufmann B, Nybakken GE, Chipman PR, Zhang W, Diamond MS, Fremont DH, Kuhn RJ, Rossmann MG. West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody. Proceedings of the National Academy of Sciences of the United States of America. 103: 12400-4. PMID 16895988 DOI: 10.1073/Pnas.0603488103  0.745
2006 Chung KM, Nybakken GE, Thompson BS, Engle MJ, Marri A, Fremont DH, Diamond MS. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. Journal of Virology. 80: 1340-51. PMID 16415011 DOI: 10.1128/Jvi.80.3.1340-1351.2006  0.702
2005 Nybakken GE, Oliphant T, Johnson S, Burke S, Diamond MS, Fremont DH. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature. 437: 764-9. PMID 16193056 DOI: 10.1038/Nature03956  0.779
2005 Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, Gorlatov S, Mehlhop E, Marri A, Chung KM, Ebel GD, Kramer LD, Fremont DH, Diamond MS. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nature Medicine. 11: 522-30. PMID 15852016 DOI: 10.1038/Nm1240  0.767
Show low-probability matches.